CGON•benzinga•
JP Morgan Initiates Coverage On CG Oncology with Overweight Rating, Announces Price Target of $41
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2025 by benzinga